Acceleron Pharma Inc. (XLRN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Acceleron Pharma Inc., with annual and quarterly history.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -43.77x | -22.27x | -16.82x | -15.82x | -16.75x | -25.41x |
| P/B Ratio | 8.50x | 6.19x | 6.84x | 4.70x | 4.23x | 14.86x |
| P/S Ratio | 78.54x | 37.59x | 142.87x | 127.25x | 34.40x | 89.73x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -180.8% | -184.4% | -889.2% | -815.8% | -238.0% | -336.4% |
| Net Margin | -179.4% | -168.7% | -849.6% | -804.5% | -205.3% | -353.1% |
| EBITDA Margin | -176.7% | -163.5% | -823.0% | -783.3% | -199.2% | -346.6% |
| Liquidity | ||||||
| Current Ratio | 14.85x | 13.48x | 16.18x | 17.03x | 9.09x | 7.66x |
| Quick Ratio | 14.85x | 13.48x | 16.18x | 17.03x | 9.09x | 7.66x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.07x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..